Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
PS1466 CYTOREDUCTION FOR THE TREATMENT OF...
Journal article

PS1466 CYTOREDUCTION FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: A SYSTEMATIC REVIEW

Abstract

Background: Cytoreductive therapies are recommended in patients with essential thrombocythemia (ET) to prevent arterial and venous thrombosis. Aims: The aim of this study was to systematically review the benefits and harms of different cytoreductive therapies in adult patients diagnosed with ET. Methods: We searched MEDLINE, EMBASE, FDA, and EMA databases from inception through 23 January 2017 for randomized trials and prospective …

Authors

Geen O; Sloan S; Chu D; Hillis C; Chen M

Journal

HemaSphere, Vol. 3, No. S1,

Publisher

Wiley

Publication Date

6 2019

DOI

10.1097/01.hs9.0000564128.13888.1d

ISSN

2572-9241

Labels

Sustainable Development Goals (SDG)